entertainment -WSS

entertainment

author：hotspot 2025-09-28 00:50:35 - browse：41

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Over the weekend, Intellia sought to assure the gene editing community that no such thing is happening. At a meeting at Cold Spring Harbor Laboratory that drew more than 400 of the field’s top scientists, the company shared more detailed information about studies it has conducted to assess the risks that renegade CRISPR components could be getting into an egg or sperm. These studies demonstrate “that there’s no evidence of vertical germline transmission of those edits,” Jonathan Phillips, head of pharmacology and toxicology at Intellia, said during a presentation Saturday.

Intellia is one of the leading companies working to advance in vivo gene editing therapies. In a landmark study published in the New England Journal of Medicine in 2021, Intellia revealed data from six patients in its trial for a transthyretin amyloidosis therapy — showing for the first time that it was possible to precisely alter the DNA of particular cells within the human body to treat disease with a one-time infusion of CRISPR. Included in the supplementary material was a redacted version of the company’s package requesting authorization to start its clinical trial. It noted that during toxicology studies in non-human primates, Intellia scientists discovered that editing had taken place at low levels in organs other than the liver, including the spleen and adrenal glands. In three out of 12 female monkeys, they also found editing in the animals’ ovaries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： AltruBio raises $225 million to develop ulcerative colitis drug

Wikipedia

WSS

Focused ultrasound for uterine fibroids: an uphill battle

iTeos Therapeutics debuts first data on TIGIT

Chemotherapy before breast cancer surgery might fuel metastasis

Deliver public health messages at the right time

Empower primary care with adequate payments and technology

HHS's proposed rule does nothing to address the climate crisis

leisure time

entertainment

focus

Apple is now the first public company to be valued at $3 trillion

Primary care doctor shortage won't be solved by free med school tuition

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

In age of alternative facts, a scholarly course on calling out crap

Prosthetic arm enables patients to feel the objects they grip

Medicare details structure of new drug price negotiation program

Novel spinal cord stimulator treats paralysis without surgery

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Brain MRIs reveal impact of 'toxic stress' on Black children

focus

Brain MRIs reveal impact of 'toxic stress' on Black children

Stigma and the return of syphilis

Do more moles mean more problems? Not so, says new study

Prosthetic arm enables patients to feel the objects they grip

Crowdfunding for medical bills sidesteps core problem, author says

Deliver public health messages at the right time

hotspot

explore

Wikipedia

Wikipedia